然而，在拉米夫定的治疗过程中，并没有有效的血清标志物能预测变异的早期发生。
However, there is no useful serum marker that can predict early emergence of mutants during LAM therapy.
目的探讨维持性血液透析（MHD）患者血液标志物对心血管疾病预测的临床意义。
Objective To explore the clinical significance of blood markers of MHD(maitenance hemedialyses) patients to the prediction of cardiovascular disease(CVD).
并且双标志物联合检测较单标志物检测对预测复发具有更高的敏感性。
Furthermore, the two-marker detection had a higher specificity for prediction of metastatic recurrence than single marker detection.
巨噬细胞成像技术可以作为一种生物标志物来证实亚临床炎症损伤，可以预测未来发生疾病的风险，同时也可以用来评价新的治疗方法。
Macrophage imaging may serve as a biomarker to identify subclinical inflamed lesions, to predict future risk, and to aid in the assessment of novel therapies.
结论：短期内骨转化标志物的变化可以预测患者骨密度对双磷酸盐治疗的远期反应。
Conclusion: in groups of patients, short-term changes in markers of bone turnover appear to be predictors of longer term BMD response and nonresponse to bisphosphonate therapy.
目的构建预测慢性肝炎肝脏炎症和纤维化程度的数学模型，评价血清纤维化标志物的应用价值。
Objective to build mathematical models for diagnosing liver inflammation and fibrosis degrees in chronic hepatitis, and to revaluate the value of serum fibrotic markers in clinical practice.
可以预测，这一极具有应用前景的分子肿瘤标志物不久将会在临床上被广泛应用。
It is expected that this promising molecular tumor marker would soon be put into routine clinical use.
目的对比、研究胃癌肝转移相关基因的差异表达，探讨胃癌肝转移相关基因差异，及作为标志物早期诊断预测胃癌肝转移的可能性。
Objective: To investigate differential expression of hepatic metastasis associated genes of gastric cancer, and evaluate it as a marker predicting liver metastasis of human gastric cancers.
我们在此研究了生物化学标志物是否可以用来预测早期NASH。
We herein investigated whether serum biochemical markers are useful for predicting early-stage NASH.
这促使人们寻找新的心血管风险的标志物来增强风险预测能力，现对心衰中相关生物标记物的意义作一综述。
This has prompted the search for novel markers of cardiovascular risk to help improve risk prediction. This article reviews the clinical significance of the detection of biomarkers in heart failure.
探讨端粒酶作为脑膜瘤标志物，在肿瘤良恶性鉴别、恶性程度评估以及预后预测等方面的意义。
Objective To explore telomerase activity in meningiomas and its significance in tumor's classification, evaluation of malignancy and prognosis.
表明这些肿瘤标志物对乳癌病人是有价值的预测指标。
It is showed that the detection of tumor mark - ers is a valuable indicator of prediction for the breast carcinoma.
由于缺乏预测进展和复发的肿瘤标志物那些有可能被治疗的更高阶段的肝细胞癌的患者被拒绝用肝移植疗法。
Potentially curable higher-stage HCC patients are denied LT due to the lack of cancer markers that predict progression and recurrence.
探讨孕中期母血清标志物及脐动脉血流用于预测不良妊娠结局的临床价值。
To investigate the clinical value of second trimester maternal serum screening and umbilical artery Doppler for prediction of adverse pregnancy outcome.
结论端粒酶有可能作为肿瘤标志物用于检测外周血中肺癌细胞和预测肿瘤复发转移。
Conclusion Telomerase activity may be an indicator for detecting lung cancer cells in peripheral blood as well as tumor metastasis and relapse.
结论端粒酶有可能作为肿瘤标志物用于检测外周血中肺癌细胞和预测肿瘤复发转移。
Conclusion Telomerase activity may be an indicator for detecting lung cancer cells in peripheral blood as well as tumor metastasis and relapse.
应用推荐